Literature DB >> 31349903

Racial disparities, cancer and response to oxidative stress.

Jie Zhang1, Zhi-Wei Ye2, Danyelle M Townsend3, Chanita Hughes-Halbert4, Kenneth D Tew2.   

Abstract

At the intersection of genetics, biochemistry and behavioral sciences, there is a largely untapped opportunity to consider how ethnic and racial disparities contribute to individual sensitivity to reactive oxygen species and how these might influence susceptibility to various cancers and/or response to classical cancer treatment regimens that pervasively result in the formation of such chemical species. This chapter begins to explore these connections and builds a platform from which to consider how the disciplines can be strengthened further.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glutathione; Glutathione S-transferases; Oxidative stress; Polymorphisms; Racial disparities; Redox

Mesh:

Year:  2019        PMID: 31349903      PMCID: PMC7104807          DOI: 10.1016/bs.acr.2019.03.012

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  178 in total

1.  Targeting health disparities: a model linking upstream determinants to downstream interventions.

Authors:  Sarah Gehlert; Dana Sohmer; Tina Sacks; Charles Mininger; Martha McClintock; Olufunmilayo Olopade
Journal:  Health Aff (Millwood)       Date:  2008 Mar-Apr       Impact factor: 6.301

2.  Metabolic gene polymorphism frequencies in control populations.

Authors:  S Garte; L Gaspari; A K Alexandrie; C Ambrosone; H Autrup; J L Autrup; H Baranova; L Bathum; S Benhamou; P Boffetta; C Bouchardy; K Breskvar; J Brockmoller; I Cascorbi; M L Clapper; C Coutelle; A Daly; M Dell'Omo; V Dolzan; C M Dresler; A Fryer; A Haugen; D W Hein; A Hildesheim; A Hirvonen; L L Hsieh; M Ingelman-Sundberg; I Kalina; D Kang; M Kihara; C Kiyohara; P Kremers; P Lazarus; L Le Marchand; M C Lechner; E M van Lieshout; S London; J J Manni; C M Maugard; S Morita; V Nazar-Stewart; K Noda; Y Oda; F F Parl; R Pastorelli; I Persson; W H Peters; A Rannug; T Rebbeck; A Risch; L Roelandt; M Romkes; D Ryberg; J Salagovic; B Schoket; J Seidegard; P G Shields; E Sim; D Sinnet; R C Strange; I Stücker; H Sugimura; J To-Figueras; P Vineis; M C Yu; E Taioli
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-12       Impact factor: 4.254

3.  Differential catalytic efficiency of allelic variants of human glutathione S-transferase Pi in catalyzing the glutathione conjugation of thiotepa.

Authors:  S K Srivastava; S S Singhal; X Hu; Y C Awasthi; P Zimniak; S V Singh
Journal:  Arch Biochem Biophys       Date:  1999-06-01       Impact factor: 4.013

Review 4.  Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites.

Authors:  A J Greenberg; C M Vachon; S V Rajkumar
Journal:  Leukemia       Date:  2011-12-23       Impact factor: 11.528

5.  Persistent Disparities Among Patients With T-Cell Non-Hodgkin Lymphomas and B-Cell Diffuse Large Cell Lymphomas Over 40 Years: A SEER Database Review.

Authors:  Jennifer A Crozier; Taimur Sher; Dongyun Yang; Abhisek Swaika; James Foran; Radhika Ghosh; Han Tun; Gerardo Colon-Otero; Kevin Kelly; Asher Chanan-Khan; Sikander Ailawadhi
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2015-06-19

Review 6.  Drug resistance in multiple myeloma.

Authors:  Pawel Robak; Izabela Drozdz; Janusz Szemraj; Tadeusz Robak
Journal:  Cancer Treat Rev       Date:  2018-09-04       Impact factor: 12.111

7.  Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.

Authors:  J W Moul; I A Sesterhenn; R R Connelly; T Douglas; S Srivastava; F K Mostofi; D G McLeod
Journal:  JAMA       Date:  1995-10-25       Impact factor: 56.272

Review 8.  Oxidative stress and proteasome inhibitors in multiple myeloma.

Authors:  Brittany C Lipchick; Emily E Fink; Mikhail A Nikiforov
Journal:  Pharmacol Res       Date:  2016-01-29       Impact factor: 7.658

9.  Differences in the tumor microenvironment between African-American and European-American breast cancer patients.

Authors:  Damali N Martin; Brenda J Boersma; Ming Yi; Mark Reimers; Tiffany M Howe; Harry G Yfantis; Yien Che Tsai; Erica H Williams; Dong H Lee; Robert M Stephens; Allan M Weissman; Stefan Ambs
Journal:  PLoS One       Date:  2009-02-19       Impact factor: 3.240

10.  Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism.

Authors:  G P Soriano; L Besse; N Li; M Kraus; A Besse; N Meeuwenoord; J Bader; B Everts; H den Dulk; H S Overkleeft; B I Florea; C Driessen
Journal:  Leukemia       Date:  2016-04-27       Impact factor: 11.528

View more
  3 in total

1.  Adaptive stress response genes associated with breast cancer subtypes and survival outcomes reveal race-related differences.

Authors:  Muthana Al Abo; Larisa Gearhart-Serna; Steven Van Laere; Jennifer A Freedman; Steven R Patierno; Eun-Sil Shelley Hwang; Savitri Krishnamurthy; Kevin P Williams; Gayathri R Devi
Journal:  NPJ Breast Cancer       Date:  2022-06-13

2.  Cross-sectional association between gamma-glutamyl transferase and hyperuricaemia: the China Multi-Ethinic Cohort (CMEC) study.

Authors:  Yanjiao Wang; Fang Xu; Xuehui Zhang; Fei Mi; Ying Qian; Rudan Hong; Wei Zou; Hua Bai; Likun He; Songmei Wang; Jianzhong Yin
Journal:  BMJ Open       Date:  2022-05-30       Impact factor: 3.006

3.  Development of Telintra as an Inhibitor of Glutathione S-Transferase P.

Authors:  Jie Zhang; Zhi-Wei Ye; Yvonne Janssen-Heininger; Danyelle M Townsend; Kenneth D Tew
Journal:  Handb Exp Pharmacol       Date:  2021
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.